Association between progression‐free survival and patients’ quality of life in cancer clinical trials
Author:
Affiliation:
1. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of MedicineBrigham and Women's Hospital Boston MA
2. Harvard Medical School Boston MA
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31957
Reference25 articles.
1. Progression-Free Survival: Meaningful or Simply Measurable?
2. The Strength of Association Between Surrogate End Points and Survival in Oncology
3. American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reply to D.J. Stewart et al;Journal of Clinical Oncology;2024-01-30
2. The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from Portugal;F1000Research;2024-01-18
3. Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs;Journal of Clinical Oncology;2023-11-10
4. Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials;Seminars in Radiation Oncology;2023-10
5. Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL;Blood;2023-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3